# TRANScribe IFT — EMS narrative generator

> EMS narrative generator (iPhone/iPad app by RollCall Technologies, LLC.)

- Source: https://appshunter.io/ios/app/transcribe-ift/id6822591937 (this page in markdown: same URL + `.md`)
- Developer: [RollCall Technologies, LLC](https://appshunter.io/developer/6822591939)
- Category: Medical, Productivity
- Price: $9.99
- Age rating: 12+
- Requires: iOS 15.0 · 2 MB
- Languages: American English
- Released: 2026-11-05
- Data updated: 2026-11-08

## What is TRANScribe IFT?

TRANScribe IFT helps EMS professionals organize interfacility transport documentation and create a structured narrative draft.

• Create BLS and CCT transport narratives
• Organize patient, assessment, transport, and handoff details
• Add optional clinical modules to tailor your forms
• Copy your draft to review and enter into your agency’s patient care record
• Reset the form when you’re ready to start another note

Personal app access requires a monthly Default Narrator subscription through Apple In-App Purchase. Optional modules are available as individual one-time purchases, with BLS and CCT module bundles also available. Prices and renewal terms are shown before purchase.

TRANScribe IFT is a documentation aid. Review and edit every draft, and follow your agency’s protocols and approved recordkeeping process. It does not replace clinical judgment or your agency’s patient care record. Information entered into this generator is processed locally on your device and is not stored on our app servers.

## Is TRANScribe IFT safe?

Not enough ratings yet to assess TRANScribe IFT.

## Is TRANScribe IFT legit?

TRANScribe IFT has limited verification signals. The AppsHunter Legitimacy Score for TRANScribe IFT is 50 out of 100 points across 7 verification signals from App Store and developer data.


## Version history (last 1 release)

### 1.0 — 2026-11-05

No release notes.

---

*Data collected daily from the US App Store and indexed by [AppsHunter](https://appshunter.io/). User reviews are verbatim App Store reviews. Ratings, prices and chart positions refresh continuously; this snapshot is from 2026-11-08.*
